Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. University of Ulsan College of Medicine, Seoul, Korea

Survival: 6.5 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Korea
City/State/Province: Seoul
Hospital: University of Ulsan College of Medicine
Journal: Link
Date: 10/2012

This phase 2 study involved 37 advanced urothelial cancer patients who were previously treated with gemcitabine and platinum-based chemotherapy. The median patient age was 57 years and 78% were male.

Patients were treated with a particular formulation of the chemotherapy agent paclitaxel called polymeric micelle formulation.

The most severe toxicities were of grade 4 and included anemia and infection. Grade 3 nerve disorders and neutropenia were also reported. Grade 1-2 alopecia was reported by 97.1% of patients.

The median overall survival was 6.5 months.

The study drug, brand name Genexol-PM, was provided by the manufacturer Samyang Co.

Correspondence: Dr. Jin-Hee Ahn; email:

E-mail to a Friend Email Physician More Information